Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression

British Journal of Ophthalmology

Volumn 89, Issue 2, 2005, Pages 147-150

  Leslie, T ^a   Lois, N ^a,b   Christopoulou, D ^a   Olson, J A ^a   Forrester, J V ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ADULT; CHOROID DISEASE; CHOROIDITIS; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DRUG MEGADOSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CHOROIDAL NEOVASCULARIZATION; MALE; OCULAR HISTOPLASMOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PUNCTATE INNER CHOROIDOPATHY; RETINA EXUDATE; RETINA FOVEA; RETINA HEMORRHAGE; REVIEW; SUBRETINA HEMORRHAGE; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; SYSTEMIC THERAPY; TREATMENT FAILURE; VISUAL ACUITY;

ADULT; ANTI-INFLAMMATORY AGENTS; CHOROID DISEASES; CHOROIDAL NEOVASCULARIZATION; CYCLOSPORINE; EYE INFECTIONS, FUNGAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HISTOPLASMOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PREDNISOLONE; RETINA; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 12944302057     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.046623     Document Type: Review

References (37)

1. Watzke RC, Packer AJ, Folk JC, et al. Punctate inner choroidopathy. Am J Ophthalmol 1984;98:572-84.
2. Krause AC, Hopkins WG. Ocular manifestation of histoplasmosis. Am J Ophthalmol 1951;34:564-6.
3. Brown J Jr, Folk JC, Reddy CV, et al. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy and the diffuse retinal fibrosis syndrome. Ophthalmology 1996;103:1100-5.
4. Kleiner RC, Ratner CM, Enger MS, et al. Subfoveal neovascularization in the ocular histoplasmosis syndrome: a natural history study. Retina 1988;8:225-9.
5. Ofk JR, Burgess DB, McCormick PA. Subfoveal and Juxtafoveal Subretinal Neovascularisation in the Presumed Ocular Histoplasmosis syndrome: visual prognosis. Ophthalmology 1984;91:1592-602.
6. Flaxel CJ, Owens SL, Mulholland B, et al. The use of corticosteroids for choroidal neovascularisation in young patients. Eye 1998;12:266-72.
7. Fine SL, Wood WJ, Isernhagen RD, et al. Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial. Arch Ophthalmol 1993;111:19-20.
8. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One year results of two randomized clinical trials - TAP report 1. Arch Ophthalmol 1999;117:1329-45.
9. Motero JA, Ruiz-Moreno JM. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol 2003;87:173-6.
10. Spaide RF, Martin ML, Slakter J, et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol 2002;134:62-8.
11. Karacorlu M, Karacorlu S, Ozdemir H, et al. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 2002;134:360.
12. Shaikh S, Ruby AJ, Williams GA. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Am J Ophthalmol 2003;135:1-6.
13. Wang LK, Kansal S, Pulido JS. Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy. Am J Ophthalmol 2002;134:790-2.
14. Spaide RF, Freund KB, Slakter J, et al. Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 2002;22:545-9.
15. Coquelet P, Postelmans L, Snyers B, et al. Successful photodynamic therapy combined with laser photocoagulation in three eyes with classic subfoveal choroidal neovascularisation affecting two patients with multifocal choroiditis: case reports. Bulletin de la Societe Belge d Ophtalmologie 2002;283:69-73.
16. Farah ME, Costa RA, Muccioli C, et al. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2002;134:137-9.
17. Dantas MA, Slakter JS, Negrao S, et al. Photodynamic therapy with verteporfin in mallatia leventinese. Ophthalmology 2002;109:296-301.
18. Valmaggia C, Niederberger H, Helbig H. Photodynamic therapy for choroidal neovascularization in fundus flavimaculatus. Retina 2002;22:111-13.
19. Battaglia Parodi M, Da Pozzo S, Toto L, et al. Photodynamic therapy for choroidal neovascularization associated with choroidal osteoma. Retina 2001;21:660-1.
20. Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy for choroidal neovascularization associated with pattern dystrophy. Retina 2003;23:171-6.
21. Potter MJ, Szabo SM, Chan EY, et al. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 2002;133:144-51.
22. Rogers AH, Greenberg PB, Martidis A, et al. Photodynamic therapy of polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers Imaging 2003;34:60-3.
23. Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy in chronic serous chorioretinopathy. Retina 2003;23:235-7.
24. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five year results from randomized clinical trials. Arch Ophthalmol 1991;109:1109-14.
25. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five year results from randomized trials. Arch Ophthalmol 1994;112:500-9.
26. Martidis A, Miller DG, Ciulla TA, et al. Corticosteroids as an antiangiogenic agent for histoplamosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther 1999;15:425-8.
27. Dees C, Arnold JJ, Forrester JV, et al. Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol 1998;116:1456-61.
28. Olsen TW, Capone A Jr, Sternberg P Jr, et al. Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 1996;103:2061-9.
29. Thomas MA, Dickinson JD, Melberg NS, et al. Visual results after surgical removal of subfoveal choroidal neovascular membranes. Oahthalmology 1994;101:1384-96.
30. Berger AS, Conway M, Del Priore LV, et al. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol 1997;115:991-6.
31. Holekamp NM, Thomas MA, Dickinson JD, et al. Surgical removal of subfoveaf choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results. Ophthalmology 1997;104:22-6.
32. Stone TW, Sternberg P Jr. Submacular surgery trials update. Ophthalmol Clin North Am 2002;15:479-88.
33. Chatterjee S, Gibson JM. Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 2003;87:925-7.
34. Rogers AH, Duker JS, Nichols N, et al. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003;110:1315-20.
35. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks and idiopathic causes. Arch Ophthalmol 2000;118:327-36.
36. Saperstein DA, Rosenfeld PJ, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology 2002;109:1499-505.
37. Busquets MA, Shah GK, Wickens J, et al. Ocular photodynomic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina 2003;23:299-306.